Background: The World Health Organization (WHO) reports estimate that 85% of newborn deaths are due to infections, prematurity and fetal distress. These conditions are risk factors for upper GI bleeding (UGIB) in sick neonates. UGIB is associated with poor neonatal outcomes such as prolonged hospitalisation and poor weight gain. The magnitude of UGIB and its contribution to neonatal morbidity has not been described in most low income countries. Objective: To determine the occurrence and factors associated with UGIB among neonates admitted to the Special Care Unit (SCU) of Mulago Hospital. Methods: This was a prospective single cohort study where neonates admitted within 24 hours of birth were consecutively enrolled and followed up for seven days. Gastric aspirates from the neonates were examined daily over a period of 7 days using Guaiac and Apt tests for evidence of UGIB. Data on occurrence of UGIB has been presented as proportions and Odds Ratios for associated factors. 
Introduction
Upper GI bleeding in neonates occurs in 10 to 40% of critically ill neonates, especially among those suffering from infections, preterm birth, thrombocytopenia and birth asphyxia [1] [2] [3] [4] . This condition is associated with poor neonatal outcomes such as prolonged hospitalization and poor weight gain. Most of the published studies have been conducted in high income countries with better neonatal care and outcomes compared to the low income countries. The magnitude of UGIB bleeding and its contribution to neonatal morbidity have not been described in most low income countries. In this paper we describe the occurrence of UGIB in a neonatal unit at Mulago Hospital, Kampala, Uganda and associated factors.
Methods

Study design and Setting
This was a prospective cohort study, conducted in November and December 2010 at the Special Care Unit (SCU) of Mulago Hospital. Mulago Hospital is a national referral hospital for Uganda and the Teaching Hospital for Makerere University. The SCU, which serves as the neonatal intensive care unit, receives ill or preterm neonates of age less than 24 hours born in or referred to Mulago Hospital.
Sample size estimation A sample size for occurrence of UGIB of 141 was based on a 10.2% prevalence of UGIB 3 using Keish Leslie formula. Based on a reported association between thrombocytopenia and UGIB 5 , a sample size 173 for factors associated with UGIB was obtained using the Fleiss formula 6 . Adding 10% loss to follow up to the larger sample size of 173, a sample size of 191 was required for the study.
Enrolment of patients
All neonates admitted to the SCU during the study period were eligible for participation. Those whose mother/caretaker provided informed consent were enrolled. Babies born before arrival to hospital, those who already had UGIB at admission and neonates older than 24 hours at enrollment were excluded. Neonates were recruited every day between 8:00 am and 8:00pm, while those admitted after 8.00pm were recruited the following morning. All the participants had a detailed physical examination including gestation age assessment using the New Ballard's scoring system.
Specimen collection and lab analysis
All the neonates had an NG tube gauge 5 inserted. At least 2 ml of gastric aspirates were collected once daily between 8-9.00 am and sent for occult blood analysis at the Clinical chemistry laboratory. Part of the sample from aspirates that tested positive for occult blood was subjected to an Apt test to determine the origin of the blood. Peripheral blood samples were taken for a complete blood count at the hematology laboratory of Mulago hospital.
Follow up
All the neonates in this study were followed up for seven days, or until they developed UGIB, or death or discharge or the attending doctors recommend removal of the NG tube, whichever came first.
Data Management
Data was collected using a structured questionnaire, entered into a database using EPI DATA 3.1 and analyzed using STATA version 10. P-values below 0.05 were considered significant using confidence intervals of 95%. Laboratory, maternal and infant characteristics were compared among infants who had UGIB versus those who did not have UGIB. Factors with a p-value of less than 0.1 were entered into logistic regression by backward stepwise method and tested for confounding and interaction to the independent variable.
Ethical considerations
Written informed consent was obtained from all the mothers of the participating neonates. Approval to carry out this study was obtained from the Institutional Research and Ethics committee of Makerere University Medical School, Mulago Hospital Ethics Committee and the Uganda National Council for Science and Technology.
Results
During the months of November and December 2010, three hundred and twenty six (326) neonates admitted to the SCU were screened, out of which 207 were eligible. As shown in figure 1, seven eligible neonates were excluded because 5 mothers refused to consent and 2 babies were abandoned and had no caretakers. A further 9 neonates were excluded from the analysis because of missing laboratory results. All the study subjects were less than 24 hours old at enrollment. The mean gestational age of the study participants was 35.0 weeks (SD 3.0) and the mean birth weight was 2.4 kg (SD 0.8). The other characteristics are shown in table 1.
Laboratory findings of study subjects Of the 191 participants, 23 had a low platelet count of < 150,000/µL. As shown in table 2, a total of 92 neonates had a positive guaiac test in their gastric aspirates. Out of these 92 neonates, 44 had a negative Apt test, indicating that the blood in the aspirates was of neonatal origin; while 48 samples with positive Apt test contained swallowed maternal blood.
Occurrence of UGIB In this study, 23.0% of the neonates followed up developed UGIB. A majority (59.0%) of those 44 neonates were male and 59.1% were term babies. Table 3 shows the diagnosis, clinical and laboratory findings associated with UGIB on bivariate analysis. As shown in table 4, factors independently associated with UGIB include cyanosis in the neonate, neonatal seizures and birth asphyxia. 
Factors associated with UGIB
Discussion
In this study, almost a quarter of the neonates developed UGIB, a figure that lies within the range of 5.5% -43.5% found by various studies 3, [7] [8] [9] [10] . The prevalence in this study is less than what some studies reported most probably because the neonates in this study had advanced gestation age and were less likely to be on mechanical ventilation and other invasive procedures. A higher figure of 43.5% 2 was reported among children diagnosed with stress ulceration, while Deerojanawong et al reported 51.8% in among children on mechanical ventilation, a recognized risk factor for UGIB 5 . A closer proportion of 20% was reported by Kuusela et al 9 while Cochran et al, found 25% of the 208 patients followed up developed UGIB 11 . Proportions as low as 6% have been reported in some studies 12, 13 which considered a general pediatric population. While ranitidine prophylaxis decreases the incidence of UGIB in critically ill children 9, 14, 15 , it is not known whether the prevalence in this study would have been lower than 23.0% had the study subjects received ranitidine prophylaxis against UGIB. As previously reported 3, 9, 16 , this study has supported the association between birth asphyxia and UGIB. UGIB in neonates with birth asphyxia has been attributed to stress of illness, which is a known risk for gastric ulceration occurring in up to 20% of patients cared for in the neonatal ICU 9 . Stress increases gastric acid secretion and plays a key role in ulceration in older children and adults 17 . In this study, most of the neonates who suffered from asphyxia were born after prolonged labor, had a low Apgar score and required resuscitation by bag and mask immediately after birth. Birth asphyxia, cyanosis in the neonate and neonatal seizures were independently associated with UGIB and no interaction between birth 1. 92% of the babies with birth asphyxia were term deliveries. 2. Of the 23 study subjects with thrombocytopenia; only 10 developed UGIB. Of these 10 subjects, 6 had mild thrombocytopenia (100,000 -150,000), 3 had moderate thrombocytopenia (50,000 -100,000) and only 1 had severe thrombocytopenia (<50,000). All the neonates in this study received routine vitamin K injection on admission, a factor that could have reduced the risk of bleeding due to deficiency of vitamin K dependent clotting factors. In this study, thrombocytopenia was found to occur among 12%, of the neonates, a figure that is much lower than the reported range of 18-35 % [18] [19] [20] . Similar to previous studies 1, 9 , this study found that thrombocytopenia was significantly associated with UGIB. However, reasonable conclusions at different degrees of thrombocytopenia could not be made, since the number for the different levels of thrombocytopenia were few. Christensen et al attributed thrombocytopenia in neonates (especially ELBW) to the effect of early onset infection, thrombi, DIC, and severe hemorrhages 19 . This study however did not establish an association between septicemia and UGIB or between septicemia and thrombocytopenia. In this study, all subjects received routine prophylactic antibiotics, an intervention that could have reduced the prevalence of septicemia and thrombocytopenia. While studies show that maternal medication (aspirin, heparin, indomethacin) increase the risk of UGIB in the neonates 16, 21 , this study did not find any such association, partly because of the small numbers since only 2 mothers were on heparin, 2 aspirin and none on warfarin.
Conclusion
In the first seven days of life, UGIB occurred in 1 in 4 neonates admitted to SCU of Mulago Hospital. Factors independently associated with UGIB include birth asphyxia, cyanosis in the neonate and neonatal seizures.
